Cargando…
Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm
Blepharospasm is a focal dystonia in which the extraocular muscles contract repetitively, leading to excessive blinking and forced eyelid closure. Botulinum toxin type A (BoNTA) is the primary symptomatic treatment for blepharospasm and its effects have been evaluated using numerous rating scales. T...
Autores principales: | Wabbels, Bettina, Jost, Wolfgang H., Roggenkämper, Peter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104001/ https://www.ncbi.nlm.nih.gov/pubmed/21221669 http://dx.doi.org/10.1007/s00702-010-0546-9 |
Ejemplares similares
-
Botulinum Toxin Therapy in Congenital Blepharospasm
por: Wabbels, Bettina
Publicado: (2014) -
Ultra-Long-Term Therapy of Benign Essential Blepharospasm with Botulinumtoxin A—30 Years of Experience in a Tertiary Care Center
por: Wabbels, Bettina, et al.
Publicado: (2022) -
Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapy
por: Jost, Wolfgang H., et al.
Publicado: (2012) -
Botulinum toxin injection into the intrinsic laryngeal muscles to treat spasmodic dysphonia: A multicenter, placebo‐controlled, randomized, double‐blinded, parallel‐group comparison/open‐label clinical trial
por: Hyodo, Masamitsu, et al.
Publicado: (2021) -
Botulinum neurotoxin treatment in jerky and tremulous functional movement disorders: a double-blind, randomised placebo-controlled trial with an open-label extension
por: Dreissen, Yasmine Emma Maria, et al.
Publicado: (2019)